An Observational Study of Patients With Dermatologic Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorTarget PharmaSolutions, Inc.
About this trial
TARGET-DERM+ is an observational research study to conduct a comprehensive review of outcomes for patients with dermatologic disease (DD) and providers who treat these patients. The study includes patients managed for DD of any etiology in usual clinical practice in the United States and addresses important clinical questions regarding the management of DD by collecting and analyzing data from patients at academic medical centers and community medical practices and/or data from providers who treat them.
Eligibility criteria
Qualifiers
Adult or pediatric participants managed for DD invited to participate OR a provider who treats patients with these conditions. Informed consent is required for all Engaged Cohort participants.
Adult or pediatric participants at the time of enrollment with a diagnosis of DD by ICD code or other relevant healthcare code as part of the EHR interface.
Disqualifiers
Participant withdrew consent; Failure to complete activities as required per the cohort clarification letter.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
2,000,000 Participants
are grouped into 2 trial groupsSponsors and collaborators
Source ClinicalTrials.gov